Cardiac myosin inhibitor aficamten improved pVO2 by 1.74 ml/kg/minute compared to placebo as measured by cardiopulmonary exercise testing (CPET) after 24 weeks. That is slightly better than was ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback